Table 2 Immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) results for HER2 protein expression and gene amplification respectively with amplification (in bold) observed in 6/33 (18.2%) mucinous carcinomas.
ID | IHC (HER2) | HER2/CEP 17 Ratio | Patient Outcome | IHC/FISH concordance |
|---|---|---|---|---|
V1 | 0 | 0.8 | ||
V2 | 3 | 8.0 | ||
V3 | 0 | 1.0 | ||
V4 | 0 | 1.1 | ||
V5 | 3 | 5+ | ||
V6 | 3 | 5.5 | ||
V7 | 0 | 1.1 | ||
V8 | 1 | 1.9 | ||
V9 | 0 | 1.2 | ||
V10 | 0 | 6.7 | Discordant | |
V11 | 0 | 1.0 | ||
V12 | 0 | 0.7 | ||
V13 | 0 | 1.0 | ||
V14 | 0 | 0.9 | Recurrent | |
V15 | 0 | 1.1 | ||
V16 | 0 | 1.1 | ||
V17 | 0 | 1.4 | Recurrent | |
V18 | 0 | 1.3 | Recurrent | |
V19 | 1 | 0.8 | Recurrent | |
V20 | 2 | 6.2 | ||
V21 | 0 | 1.5 | Recurrent | |
V22 | 0 | 1.2 | ||
V23 | 0 | 1.2 | ||
V24 | 0 | 1.7 | Recurrent | |
V25 | 0 | 1.1 | ||
V26 | 0 | 0.9 | ||
V27 | 0 | 1.0 | Recurrent | |
V28 | 3 | 5.1 | ||
V29 | 1 | 1.3 | ||
V30 | 0 | 1.0 | ||
V31 | 0 | 1.2 | Recurrent | |
V32 | 0 | 1.4 | Recurrent | |
V33 | 0 | 1.0 | Recurrent |